Article
Anoctamin 5 mutation leads to abnormal bone homeostasis of GDD by regulating AMPK-dependent glucose metabolism.
Frontiers in endocrinology - 1 Jan 2026
Li Hongyu, Xu Huichong, Sun Kaiwen, Wang Shengnan, Zhang Mingyue, Lin Liqi, Zhang Shuai, Dong Rui, Hu Ying
Abstract excerpt
Introduction: Gnathodiaphyseal Dysplasia (GDD) characterized by enhanced bone mass and spontaneous fractures is a rare autosomal dominant genetic disease caused by Anoctamin 5 (ANO5) mutations. Deletion or mutation in ANO5 exhibited abnormal bone metabolism of GDD manifested by increased osteogenesis and reduced osteoclastogenesis. However, the mechanism is not fully understood. Methods: Ano5Cys360Ty r knock-in...
Topics
Join the communities discussing this publication.
